FRONT-LINE DOSE-DENSE WEEKLY PACLITAXEL WITH 3-WEEKLY CARBOPLATIN FOR ADVANCED EPITHELIAL OVARIAN CANCER (EOC) - A SINGLE ASIAN INSTITUTION'S EXPERIENCE

被引：0
|
作者：
Chia, L. [1 ]
Lim, E. [2 ]
Lim, S. L. [3 ]
Goh, X. N. [2 ]
Chan, A. [1 ]
Cheong, H. H. [2 ]
Lin, X. H. [3 ]
Lim, Y. K. [3 ]
Yam, K. L. [3 ]
Chia, W. K. [3 ]
Soh, L. T. [3 ]
Foo, K. M. [2 ]
机构：
[1] Natl Univ Singapore, Pharm, Singapore 117548, Singapore
[2] KK Womens & Childrens Hosp, Pharm, Singapore, Singapore
[3] KK Womens & Childrens Hosp, Dept Gynaecol Oncol, Singapore, Singapore
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0580
引用
收藏
页码：443 / 443
页数：1
相关论文
共 50 条
  • [1] Dose-dense chemotherapy with weekly paclitaxel and 3-weekly carboplatin for recurrent ovarian cancer
    Chen, Wei-Chun
    Huang, Huei-Jean
    Chang, Ting-Chang
    Chou, Hung-Hsueh
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2020, 59 (01): : 21 - 27
  • [2] EXPERIENCE OF WEEKLY DOSE DENSE CARBOPLATIN AND PACLITAXEL IN PLATINUM RESISTANT OVARIAN CANCER
    Roxburgh, P.
    Sharma, R.
    Brooks, A.
    Reed, N.
    Gabra, H.
    Glasspool, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 212 - 212
  • [3] DOSE-DENSE WEEKLY CARBOPLATIN AND PACLITAXEL AS NEOADJUVANT CHEMOTERAPY IN LOCALLY ADVANCED CERVICAL CANCER
    Crupano, F. M.
    Cormio, G.
    Loizzi, V.
    Del Vecchio, V.
    Fumarulo, V. V.
    Minicucci, V.
    Murgia, F.
    Grasso, S.
    Camporeale, A.
    Leone, L.
    Resta, L.
    Cicinelli, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 322 - 322
  • [4] Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort
    Pirolli, Rafaela
    Loiola de Alencar, Viviane Teixeira
    Estati, Felipe Leonardo
    Goncalves Ribeiro, Adriana Regina
    Tsuji Honda, Daniella Yumi
    de Oliveira, Mariana
    Nogueira Lima, Joao Paulo da Silveira
    Santana dos Santos, Elizabeth
    Gadelha Guimaraes, Andrea Paiva
    Baiocchi, Glauco
    Anastacio da Costa, Alexandre Andre Balieiro
    BMC CANCER, 2021, 21 (01)
  • [5] Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
    Kim, Yoo-Na
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (02)
  • [6] Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort
    Rafaela Pirolli
    Viviane Teixeira Loiola de Alencar
    Felipe Leonardo Estati
    Adriana Regina Gonçalves Ribeiro
    Daniella Yumi Tsuji Honda
    Mariana de Oliveira
    Joao Paulo da Silveira Nogueira Lima
    Elizabeth Santana dos Santos
    Andrea Paiva Gadelha Guimarães
    Glauco Baiocchi
    Alexandre André Balieiro Anastácio da Costa
    BMC Cancer, 21
  • [7] Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
    Lee, Matilda X.
    Tan, David S. P.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (06)
  • [8] Weekly dose-dense paclitaxel and carboplatin in recurrent ovarian carcinoma: A phase II trial
    Shawky, Hanan
    Tawfik, Hesham
    Hewidy, Medhat
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2014, 26 (03) : 139 - 145
  • [9] SWITCHING TO WEEKLY CARBOPLATIN/PACLITAXEL AFTER INSUFFICIENT RESPONSE TO 3-WEEKLY NEO-ADJUVANT CHEMOTHERAPY FOR ADVANCED STAGE EPITHELIAL OVARIAN CANCER
    van Soolingen, N. J.
    Sonke, G. S.
    van Driel, W. J.
    Stouthard, J. M.
    Kenter, G. G.
    Lok, C. A. R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1525 - 1525
  • [10] Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer)
    Gonzalez-Martin, Antonio
    Gladieff, Laurence
    Tholander, Bengt
    Stroyakovsky, Daniel
    Gore, Martin
    Scambia, Giovanni
    Oaknin, Ana
    Sneller, Vesna
    Freudensprung, Ulrich
    Pignata, Sandro
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (04) : 862 - 863
12345